Cilostazol improves long-term outcomes after coronary stent implantation

American Heart Journal

Volumn 150, Issue 3, 2005, Pages 568.e1-568.e5

  Han, Yaling ^a   Wang, Shouli ^a   Li, Yi ^a   Jing, Quanmin ^a   Ma, Yingyan ^a   Deng, Jie ^a   Yang, Guitang ^a   Yu, Haibo ^a   Ge, Junbo ^b  

^a Northern Hospital   (China)

^b ZHONGSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; TICLOPIDINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; FEMALE; FOLLOW UP; GRANULOCYTOPENIA; HEADACHE; HUMAN; IN-STENT RESTENOSIS; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; TREATMENT OUTCOME;

EID: 24944494883     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.06.021     Document Type: Article

References (30)

1. A. Schömig, F.J. Neumann, and A. Kastrati A randomized comparison of antiplatelet with anticoagulant therapy after the placement of coronary artery stents N Engl J Med 334 1996 1084 1089
2. M.B. Leon, D.S. Baim, and J.J. Popma A clinical trial comparing three antithrombotic drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators N Engl J Med 339 1998 1665 1671
3. P. Urban, C. Macaya, and H.J. Rupprecht Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS) Circulation 98 1998 2126 2132
4. A. Kastrati, H. Schuhlen, and J. Hausleiter Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial Circulation 96 1997 462 467
5. C.M. Goods, K.F. al-Shaibi, and M.W. Liu Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting Am J Cardiol 78 1996 1042 1044
6. S. Take, M. Matsutani, and H. Ueda Effect of cilostazol in preventing restenosis after percutaneous transluminal coronary angioplasty Am J Cardiol 79 1997 1097 1099
7. T. Kunishima, H. Musha, and F. Eto A randomized trial of aspirin versus cilostazol therapy after successful coronary stent implantation Clin Ther 19 1997 1058 1066
8. K. Kozuma, K. Hara, and M. Yamasaki Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation Am Heart J 141 2001 124 130
9. S.W. Park, C.W. Lee, and H.S. Kim Effects of cilostazol on angiographic restenosis after coronary stent placement Am J Cardiol 86 2000 499 503
10. J.A. Spertus, J.A. Winder, and T.A. Dewhurst Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease J Am Coll Cardiol 25 1995 333 341
11. H. Umekawa, T. Tanaka, and Y. Kimura Purification of cyclic adenosine monophosphate phosphodiesterase from human platelets using new-inhibitor sepharose chromatography Biochem Pharmacol 33 1984 3339 3344
12. S.W. Park, C.W. Lee, and H.S. Kim Comparison of cilostazol versus ticlopidine therapy after stent implantation Am J Cardiol 84 1999 511 514
13. M. Ochiai, T. Isshiki, and S. Takeshita Use of cilostazol, a novel antiplatelet agent, in a post-Palmaz-Schatz stenting regimen Am J Cardiol 79 1997 1471 1474
14. H. Kamishirado, T. Inoue, and K. Mizoguchi Randomized comparison of cilostazol versus ticlopidine hydrochloride for antiplatelet therapy after coronary stent implantation for prevention of late restenosis Am Heart J 144 2002 303 308
15. S. Takahashi, K. Oida, and R. Fujiwara Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture J Cardiovasc Pharmacol 20 1992 900 906
16. N. Ishizaka, J. Taguchi, and Y. Kimura Effects of a single local administration of cilostazol on neointimal formation in balloon-injured rat carotid artery Atherosclerosis 142 1999 41 46
17. N. Nagaoka, T. Matsubara, and K. Okazaki Comparison of ticlopidine and cilostazol for the prevention of restenosis after percutaneous transluminal coronary angioplasty Jpn Heart J 42 2001 43 54
18. M. Sekiguchi, H. Hoshizaki, and H. Adachi Effects of antiplatelet agents on subacute thrombosis and restenosis after successful coronary stenting: a randomized comparison of ticlopidine and cilostazol Circ J 68 2004 610 614
19. J.J. Popma, P. Berger, and E.M. Ohman Antithrombotic therapy during percutaneous coronary intervention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest 126 3 Suppl 2004 5761S 5799S
20. R.A. Lange, and L.D. Hillis Antiplatelet therapy for ischemic heart disease N Engl J Med 350 2004 277 280
21. S.R. Mehta, S. Yusuf, and R.J. Peters Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533
22. S.R. Steinhubl, P.B. Berger, and J.T. Mann III Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420
23. E. Tsuchikane, Y. Takeda, and K. Nasu Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS Catheter Cardiovasc Interv 63 2004 44 51
24. M. Yasutake, T. Kunimi, and N. Sato Effects of a single oral dose of cilostazol on epicardial coronary arteries and hemodynamics in humans Circ J 66 2002 241 246
25. M. Aoki, R. Morishita, and S. Hayashi Inhibition of neointimal formation after balloon injury by cilostazol, accompanied by improvement of endothelial dysfunction and induction of hepatocyte growth factor in rat diabetes model Diabetologia 44 2001 1034 1042
26. M.B. Elam, J. Heckman, and J.R. Crouse Effect of the novel antiplatelet agent cilostazol on plasma lipoproteins in patients with intermittent claudication Arterioscler Thromb Vasc Biol 18 1998 1942 1947
27. Y. Tanabe, E. Ito, and I. Nakagawa Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine Int J Cardiol 78 2001 285 291
28. K. Watanabe, S. Ikeda, and J. Komatsu Effect of cilostazol on vasomotor reactivity in patients with vasospastic angina pectoris Am J Cardiol 92 2003 21 25
29. F. Gotoh, H. Tohgi, and S. Hirai Cilostazol stroke prevention study: a placebo-controlled double-blind trial for secondary prevention of cerebral infarction J Stroke Cerebrovasc Dis 9 2000 147 157
30. S.J. Park, W.H. Shim, and D.S. Ho A paclitaxel-eluting stent for the prevention of coronary restenosis N Engl J Med 348 2003 1537 1545